Historical record - last NADAC effective date: 4/19/2017
Product Information
RYNEX PSE LIQUID is a generic product labeled by Edwards Pharmaceuticals, Inc., priced at $0.0364 per ML under NDC 00485020616. Its NADAC has been published 52 times since Apr 19, 2017.
Strength
1; 15 mg/5mL; mg/5mL
Manufacturer
Edwards Pharmaceuticals, Inc.NDC
00485020616
Classification
Generic
Dosage Form
LIQUID
Route
ORAL
Effective Date
4/19/2017
Active Ingredients
BROMPHENIRAMINE MALEATE; PSEUDOEPHEDRINE HYDROCHLORIDEApproval Type
OTC MONOGRAPH DRUG
FDA Application
M012On Market Since
3/7/2011
Pharmacological Classes
Price Statistics
The NADAC for RYNEX PSE LIQUID has been published 52 times since Apr 19, 2017, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0364 per ML |
|---|---|
| All-time high | $0.0364 (Apr 11, 2018) |
| All-time low | $0.0364 (Apr 19, 2017) |
| Median price | $0.0364 |
| Average price | $0.0364 |
| Largest weekly change | 0.0% (Apr 26, 2017) |
| Weeks tracked | 52 |
| Tracking since | Apr 19, 2017 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
N/A
All
0.0%
Last surveyed Apr 11, 2018 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the BROMPHENIRAMINE MALEATE and PSEUDOEPHEDRINE HYDROCHLORIDE market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Edwards Pharmaceuticals, Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
BROMPHENIRAMINE MALEATE and PSEUDOEPHEDRINE HYDROCHLORIDE market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
alpha-Adrenergic Agonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of RYNEX PSE LIQUID?
The current National Average Drug Acquisition Cost (NADAC) for RYNEX PSE LIQUID, manufactured by Edwards Pharmaceuticals, Inc., is $0.0364 per ML (NDC 00485020616), effective Apr 11, 2018.
How has the price of RYNEX PSE LIQUID changed over time?
Over the history we have for it, the NADAC for RYNEX PSE LIQUID has held within roughly two percent of its current level. It has been tracked across 52 weekly CMS publications since Apr 19, 2017.
What are the highest and lowest recorded NADAC prices for RYNEX PSE LIQUID?
Since Apr 19, 2017, the NADAC for RYNEX PSE LIQUID has ranged from a low of $0.0364 (Apr 19, 2017) to a high of $0.0364 (Apr 11, 2018), with a median of $0.0364 per ML.
Are there cheaper alternatives to RYNEX PSE LIQUID?
No other NADAC-published product currently shares the active ingredient and strength of RYNEX PSE LIQUID in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures RYNEX PSE LIQUID?
RYNEX PSE LIQUID (NDC 00485020616) is labeled by Edwards Pharmaceuticals, Inc., and CMS classifies it as a generic product.